The WHO included a caveat that the growth estimate is based on data from just one country, the United States.
WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Global, US data show high antibiotic use, rise in resistant infections during COVID
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
- Study reveals promising results for abatacept for severe COVID
- Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy